Anthony Petrone
Stock Analyst at Mizuho
(3.56)
# 838
Out of 4,412 analysts
125
Total ratings
48.45%
Success rate
4.64%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $80 → $85 | $73.17 | +16.17% | 5 | Apr 25, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $45 → $53 | $46.96 | +12.86% | 6 | Apr 11, 2024 | |
| NVRO Nevro | Maintains: Neutral | $20 → $16 | $11.32 | +41.34% | 3 | Apr 11, 2024 | |
| GKOS Glaukos | Maintains: Neutral | $85 → $100 | $99.48 | +0.52% | 5 | Apr 11, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $105 | $86.43 | +21.49% | 7 | Apr 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $96 → $110 | $86.24 | +27.55% | 5 | Apr 11, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Buy | $50 → $65 | $48.47 | +34.10% | 5 | Apr 1, 2024 | |
| RMD ResMed | Maintains: Buy | $215 | $218.06 | -1.40% | 8 | Mar 27, 2024 | |
| LIVN LivaNova | Maintains: Buy | $75 | $55.53 | +35.06% | 5 | Mar 27, 2024 | |
| INSP Inspire Medical Systems | Maintains: Buy | $250 | $237.45 | +5.29% | 6 | Mar 27, 2024 | |
| TARS Tarsus Pharmaceuticals | Maintains: Buy | $30 → $44 | $32.04 | +37.33% | 1 | Mar 6, 2024 | |
| MDXG MiMedx Group | Maintains: Buy | $13 → $14 | $6.27 | +123.29% | 4 | Mar 1, 2024 | |
| ALC Alcon | Maintains: Buy | $95 → $100 | $78.77 | +26.95% | 6 | Mar 1, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $9 → $10 | $6.55 | +52.67% | 4 | Mar 1, 2024 | |
| COO The Cooper Companies | Maintains: Buy | $103 → $115 | $88.84 | +29.45% | 13 | Mar 1, 2024 | |
| MDT Medtronic | Maintains: Buy | $95 → $98 | $79.74 | +22.90% | 4 | Feb 21, 2024 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $350 → $390 | $375.33 | +3.91% | 6 | Jan 25, 2024 | |
| TFX Teleflex | Maintains: Neutral | $225 → $235 | $206.71 | +13.69% | 6 | Nov 3, 2023 | |
| LNTH Lantheus Holdings | Reiterates: Buy | $125 | $65.56 | +90.67% | 4 | Oct 4, 2023 | |
| LMAT LeMaitre Vascular | Downgrades: Hold | $63 → $67 | $65.46 | +2.35% | 2 | Aug 3, 2023 | |
| ABT Abbott Laboratories | Assumes: Neutral | $110 → $115 | $107.53 | +6.95% | 3 | Jul 21, 2023 | |
| AXNX Axonics | Reiterates: Buy | $75 | $66.69 | +12.46% | 2 | Jul 14, 2023 | |
| HOLX Hologic | Reiterates: Buy | $95 | $75.98 | +25.03% | 6 | Jun 15, 2023 | |
| HAE Haemonetics | Maintains: Buy | $110 → $115 | $90.99 | +26.39% | 6 | Feb 8, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | n/a | $119.35 | - | 1 | Nov 5, 2021 | |
| AGTI Agiliti | Initiates: Buy | n/a | $10.05 | - | 1 | May 18, 2021 | |
| VREX Varex Imaging | Downgrades: Hold | n/a | $16.79 | - | 1 | Feb 12, 2020 |
Boston Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $73.17
Upside: +16.17%
STAAR Surgical Company
Apr 11, 2024
Maintains: Buy
Price Target: $45 → $53
Current: $46.96
Upside: +12.86%
Nevro
Apr 11, 2024
Maintains: Neutral
Price Target: $20 → $16
Current: $11.32
Upside: +41.34%
Glaukos
Apr 11, 2024
Maintains: Neutral
Price Target: $85 → $100
Current: $99.48
Upside: +0.52%
Edwards Lifesciences
Apr 11, 2024
Maintains: Buy
Price Target: $95 → $105
Current: $86.43
Upside: +21.49%
GE HealthCare Technologies
Apr 11, 2024
Maintains: Buy
Price Target: $96 → $110
Current: $86.24
Upside: +27.55%
Establishment Labs Holdings
Apr 1, 2024
Reiterates: Buy
Price Target: $50 → $65
Current: $48.47
Upside: +34.10%
ResMed
Mar 27, 2024
Maintains: Buy
Price Target: $215
Current: $218.06
Upside: -1.40%
LivaNova
Mar 27, 2024
Maintains: Buy
Price Target: $75
Current: $55.53
Upside: +35.06%
Inspire Medical Systems
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $237.45
Upside: +5.29%
Tarsus Pharmaceuticals
Mar 6, 2024
Maintains: Buy
Price Target: $30 → $44
Current: $32.04
Upside: +37.33%
MiMedx Group
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.27
Upside: +123.29%
Alcon
Mar 1, 2024
Maintains: Buy
Price Target: $95 → $100
Current: $78.77
Upside: +26.95%
ADMA Biologics
Mar 1, 2024
Maintains: Buy
Price Target: $9 → $10
Current: $6.55
Upside: +52.67%
The Cooper Companies
Mar 1, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $88.84
Upside: +29.45%
Medtronic
Feb 21, 2024
Maintains: Buy
Price Target: $95 → $98
Current: $79.74
Upside: +22.90%
Intuitive Surgical
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $375.33
Upside: +3.91%
Teleflex
Nov 3, 2023
Maintains: Neutral
Price Target: $225 → $235
Current: $206.71
Upside: +13.69%
Lantheus Holdings
Oct 4, 2023
Reiterates: Buy
Price Target: $125
Current: $65.56
Upside: +90.67%
LeMaitre Vascular
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $65.46
Upside: +2.35%
Abbott Laboratories
Jul 21, 2023
Assumes: Neutral
Price Target: $110 → $115
Current: $107.53
Upside: +6.95%
Axonics
Jul 14, 2023
Reiterates: Buy
Price Target: $75
Current: $66.69
Upside: +12.46%
Hologic
Jun 15, 2023
Reiterates: Buy
Price Target: $95
Current: $75.98
Upside: +25.03%
Haemonetics
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $90.99
Upside: +26.39%
Zimmer Biomet Holdings
Nov 5, 2021
Maintains: Buy
Price Target: n/a
Current: $119.35
Upside: -
Agiliti
May 18, 2021
Initiates: Buy
Price Target: n/a
Current: $10.05
Upside: -
Varex Imaging
Feb 12, 2020
Downgrades: Hold
Price Target: n/a
Current: $16.79
Upside: -